Institute of Biomedical Research Corp. MRES OTC

Other OTC • Healthcare • Biotechnology • ME • USD

SharesGrow Score

42/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Institute of Biomedical Research Corp. (MRES) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 40/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

42/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

25/100

→ Income

✗

健康

33/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

43/100

→ Income

✓

成长

100/100

→ Income

✗

收入

10/100

→ Income

估值概览 — MRES

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率113.03

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2006	$-0.13	$0.00	$-176.88K	-
2007	$-0.39	$0.00	$-690.3K	-
2008	$-1.88	$0.00	$-5.37M	-
2009	$-0.09	$0.00	$-443.29K	-
2010	$-0.05	$0.00	$-273.4K	-
2020	$0.00	$0.00	$-44.24K	-
2021	$0.00	$0.00	$-167.01K	-
2022	$0.00	$29.44K	$-433.41K	-1472%
2023	$0.00	$45.07K	$1.33M	2950.3%
2024	$0.00	$49.49K	$-632.72K	-1278.6%